Jeez your just asking this now? It's a little late, if we'd only known!!! Ohh.. wait did you say bio-equivalency? Whew I thought you wanted a baloney on me knee study.. here you go..
September 21, 2010 Results of Linjeta(TM) Study Versus Insulin Lispro
Biodel Inc. (Nasdaq: BIOD) today presented the results of a clinical study evaluating a new pH-neutral formulation of Linjeta(TM) Dr. Tim Heise ) and colleagues reported that the new pH-neutral, 100 IU/ml formulation of Linjeta(TM) was bioequivalent to the previously studied pH-4, 25 IU/ml formulation of Linjeta(TM). http://investor.biodel.com/releasedetail.cfm?ReleaseID=509352